Should I buy Ramsay Health Care stock in 2025?

Why trust HelloSafe ?

At HelloSafe, our expert has been tracking the performance of Ramsay Health Care for over three years. Every month, hundreds of thousands of users in Australia trust us to decipher market trends and identify the best investment opportunities. Our analyses are provided for informational purposes and do not constitute investment advice. In accordance with our ethical charter, we have never been, and will never be, compensated by Ramsay Health Care.

What is Ramsay Health Care?

The Ramsay Health Care Stock Price

The price of Ramsay Health Care stock is rising this week. The current share price is AUD 38.68, showing a 24-hour gain of 0.60% and a notable 8.04% increase over the week. Ramsay Health Care’s market capitalisation is AUD 8.93 billion, with an average three-month trading volume of about 692,500 shares. The P/E Ratio sits at 483.50, dividend yield is 2.13%, and the stock’s beta is 0.51, reflecting moderate volatility. With strong recent momentum and a positive sector outlook, investors may see potential in the current upward trend.

Our full analysis on the Ramsay Health Care stock

After analysing Ramsay Health Care’s most recent financial statements and reviewing its share price performance over the past three years, we have combined multiple sources—ranging from key financial metrics and technical signals to market data and sector peer benchmarks—through our proprietary algorithms. This comprehensive approach enables us to capture not just current results, but emerging competitive dynamics and underlying value drivers. So, why might Ramsay Health Care stock once again become a strategic entry point into the Australian healthcare sector in 2025?

Recent performance and market context

Ramsay Health Care has seen a distinct turnaround in 2025, reflecting renewed investor interest and resilient sector dynamics. As of early July 2025, the stock is trading at AUD 38.68, up 0.60% over the last trading session, and has delivered a robust 8.04% gain over the week—part of a sustained 11.76% rally over the past six months. Despite a challenging prior year, where the stock declined by 16.67%, the company’s market capitalisation remains strong at AUD 8.93 billion, supported by average daily volumes exceeding 690,000 shares. The appointment of Natalie Davis as CEO in October 2024 has infused a new strategic direction focused on operational excellence and digital innovation. Australia’s demographic tailwinds—primarily driven by a rapidly aging population and the growing demand for private healthcare—set a compelling backdrop for Ramsay’s continued recovery and margin improvement.

Ramsay’s robust international footprint, with more than 500 healthcare facilities globally, further inoculates it against localised sector risks and provides ample diversification. Recent financial disclosures highlighted that the company is outperforming consensus expectations, especially on revenue growth and EBITDA, even as it faces sector-wide cost pressures and ongoing transformation initiatives. In a climate where healthcare remains structurally essential and defensive, the combination of steady demand, government support, and expanding insurance coverage bodes well for sustainable earnings growth and above-market resilience.

Technical analysis

A review of Ramsay Health Care’s chart and technical sentiment reveals clear signals that reinforce a positive bias for new buyers. The Relative Strength Index (RSI) currently stands at 71.57—a figure nudging the borderline of the overbought zone, yet this reflects the market’s strong confidence following recent upgrades and strategic newsflow. The MACD at 0.22 produces a distinct bullish signal, while all key moving averages (from 5-day through to 200-day) are currently flashing “buy” signals, confirming a synchronised upward momentum across short, mid, and long-term timeframes.

Importantly, the current price is testing key resistance around the AUD 38.68 mark. Strong support sits at AUD 33.42 and, should broader market sentiment turn, a further floor appears at AUD 31.66. Bullish reversal signals are notable, with ongoing accumulation patterns and high trade volumes suggesting institutional interest. For investors seeking a technical entry, Ramsay Health Care’s alignment of upward-moving averages and robust momentum underpins the idea that the present consolidation phase could be the precursor to a new bullish leg—especially as the sector’s fundamentals continue to strengthen.

Fundamental analysis

The fundamental narrative for Ramsay Health Care is deeply attractive, underpinned by multiple levers of growth and value creation. Half-year 2025 results delivered revenue of AUD 8.54 billion (+5.7% year-on-year) and EBITDA of AUD 1.53 billion, with both metrics exceeding analyst expectations. The company’s annualised revenue trajectory is similarly robust, and even though net profit briefly dipped due to exceptional items, the underlying core operations remain healthy and are on an improving trend.

Ramsay’s valuation deserves close attention. While the Price/Earnings (P/E) ratio stands at 483.50 (reflecting prior extraordinary charges and a temporary earnings contraction), this headline figure masks a business entering a new phase of profitability as restructuring and operational efficiency strategies take hold. Dividend yield is 2.13% (with fully franked dividends providing tax advantages for Australians), a testament to management’s commitment to shareholder returns even during industry adjustments.

• One of Australia’s largest healthcare operators, with proven scalability across more than 500 sites worldwide.
• Technological and digital innovation, with continued investments aimed at boosting efficiency, patient experience, and cost control.
• Market share leadership in both Australian and European private hospital markets, supporting resilient top-line performance against varying economic or regulatory backdrops.
• Resilience in the face of macro shocks, allowing adaptation to shifts in policy, insurance, and demand environments.

Volume and liquidity

Ramsay Health Care’s strong volume profile—averaging around 692,000 shares traded daily—ensures high liquidity, providing robust opportunities for both retail and institutional investors to participate without unfavourable pricing impact. This healthy turnover reflects ongoing market confidence and attention, allowing for dynamic revaluation as catalysts arise.

With 181.51 million shares outstanding, the float remains sufficiently dispersed to minimise volatility from concentrated transactions, but also liquid enough to support active investment approaches and immediate portfolio rebalancing. The ability to quickly absorb larger buy or sell orders is a hallmark of major, resilient stocks and enhances the appeal of Ramsay Health Care for diversified asset managers and active traders alike.

Catalysts and positive outlook

• Demographic growth and tailwinds: An aging population in Australia and Europe is fuelling demand for advanced private healthcare, specialist treatments, and long-term care—sectors where Ramsay holds a dominant presence.
• Digital transformation and process innovation: Strategic investments in healthcare technology, digital patient pathways, and data-driven operations are already manifesting in margin improvements and future growth avenues.
• Geographic expansion: Continued international acquisitions and organic growth initiatives are diversifying earnings and reducing reliance on any single market. Entry into new segments such as specialist outpatient care and rehabilitation brings additional scale and synergy.
• ESG and sustainability leadership: Ramsay’s proactive stance on environmental, social, and governance factors differentiates it within the sector. Responsible sourcing, strong governance, and community engagement contribute to growing institutional and retail investor interest.
• Regulatory and reimbursement stability: Government support for private healthcare and coverage expansion through insurance distinguish the sector’s medium-term outlook from cyclical industries.
• Operational leadership: The recent CEO transition marks a renewed focus on operational excellence, cost control, and profitable growth.

Each of these factors represents a solid reason to expect sustained and increasing enterprise value, especially in a sector synonymous with defensive, recession-resistant cash flows.

Investment strategies

• Short-term entry: A technical “breakout” from current resistances (AUD 38.68) may unlock rapid appreciation, while any minor consolidation toward support (AUD 33–35) offers attractive entry for value-seeking buyers. Trading activity and positive news cadence should support further rebounds.
• Medium-term positioning: With financials improving, cost controls being realised, and business transformation accelerating, Ramsay’s earnings outlook looks set to benefit from a wave of multi-year sector tailwinds (demographics, digital health, and regulatory stability). Investors could anticipate re-rating as headline earnings normalise and technical signals shift from overbought to bullish confirmation.
• Long-term approach: As a clear market leader with embedded brand equity, high barriers to entry, and proven crisis resilience, Ramsay Health Care is emerging as a potential anchor stock for portfolios targeting dependable growth and solid, tax-advantaged dividends in the Australian context.

A disciplined approach at or near technical support levels, or ahead of earnings catalysts and innovation milestones, seems to represent an excellent opportunity for long-term and growth-oriented investors alike.

Is it the right time to buy Ramsay Health Care?

In summary, Ramsay Health Care stands out as one of Australia’s defensive growth leaders, with a unique blend of market share, resilience, and innovation credentials. At a time when secular healthcare demand is poised to accelerate—and with the company’s technicals, liquidity, and management direction stacked in favour of further gains—the fundamentals justify renewed interest. The occurrence of a positive earnings surprise, management-driven margin upgrades, or further inorganic expansion could serve as a significant catalyst for revaluation.

Above all, Ramsay Health Care’s current positioning, combined with momentum in its operational turnaround and a clear demographic growth story, means the stock may be entering a new bullish phase. For investors seeking reliable exposure to the healthcare sector—one of the market’s most robust and forward-looking industries—Ramsay Health Care seems exceptionally well-placed to capture future value, income, and resilience.

Ramsay Health Care remains a high-quality, defensive growth stock that offers attractive exposure to rising healthcare demand and digital transformation. The recent strong move in the share price is a sign of growing optimism in the sector, and for well-informed investors, this may mark an emerging opportunity to benefit from one of Australia’s pivotal healthcare franchises in the years ahead.

How to buy Ramsay Health Care stock in Australia?

Buying Ramsay Health Care stock online is simple and secure with a regulated Australian broker. You can choose between two main ways: buying shares directly for long-term ownership, or trading via CFDs for more flexible and leveraged exposure. Both methods are accessible and offer distinct advantages depending on your investment goals. For help with choosing the right platform, see our broker comparison further down the page.

Cash buying

Cash buying means you purchase Ramsay Health Care shares directly on the ASX, becoming a shareholder with full entitlement to dividends and voting rights. Brokers usually charge a fixed commission per order, commonly between $5 and $10 in Australia.

Gain scenario

If the Ramsay Health Care share price is $38.68 AUD, you can buy around 25 shares with a $1,000 stake, including a brokerage fee of around $5.

If the share price rises by 10%, your shares are now worth $1,100.

Result: +$100 gross gain, i.e. +10% on your investment.

Trading via CFD

CFD trading lets you speculate on Ramsay Health Care share price movements without owning the actual shares. You pay the spread (difference between buy and sell price), and may incur overnight financing fees if your position is leveraged and kept open. CFDs suit active traders who seek flexibility, leverage, and the ability to go long or short, but they involve higher risk.

CFD Gain Scenario: Ramsay Health Care

You open a CFD position on Ramsay Health Care shares, with 5x leverage and a $1,000 stake. This gives you a market exposure of $5,000.

✔️ Gain scenario:

If the stock rises by 8%, your position gains 8% × 5 = 40%. Result: +$400 gain, on a bet of $1,000 (excluding fees).

Final advice

Before investing, always compare brokers’ fees, platforms, and terms, as these can greatly affect your returns. Whether you buy shares outright or trade CFDs depends on your risk appetite, strategy, and financial objectives. For a detailed comparison of Australian brokers, scroll to the dedicated section further down this page.

Our 7 tips for buying Ramsay Health Care stock

The latest news about Ramsay Health Care

Ramsay Health Care stock posts an 8% gain over the past week on sustained buying momentum. The share price closed at AUD 38.68, representing a 0.60% rise in the last 24 hours and an 8.04% jump across the last week, reflecting renewed investor optimism in the Australian healthcare sector and positive sentiment from technical analysts.

All major moving averages flash buy signals for Ramsay Health Care shares as of this week. Current technical indicators—including the 5, 10, 20, 50, 100, and 200-day moving averages—consistently rate the stock as a “buy.” This rare alignment indicates strong short- and medium-term support for the stock price, reinforcing confidence among market participants.

Analysts note revenue outperformance and robust operating results in the latest financial update. For the most recent semi-annual period ending December 2024, Ramsay Health Care reported revenues of AUD 8.54 billion—a 5.7% year-on-year increase—surpassing market expectations. This strong performance underlines the group’s resilience and highlights growth in its Australian operations.

A new CEO, Natalie Davis, accelerates innovation and operational excellence in Australia. Since October 2024, the strategic focus on operational excellence and healthcare technology investments has intensified under her leadership, paving the way for digital transformation and enhanced efficiency across the group’s extensive hospital network in Australia.

Ramsay Health Care continues to deliver fully franked dividends to Australian shareholders. The interim dividend was maintained at AUD 0.40 per share, entirely franked, providing significant tax benefits to Australian residents and reinforcing the company’s reputation for stable, investor-friendly returns within the local context.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.